Sonja Nelson
Director of Finance/CFO en AMBRX INC .
Fortuna: 147 $ al 31/03/2024
Cargos activos de Sonja Nelson
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MOTUS GI HOLDINGS, INC. | Director/Board Member | 22/06/2021 | - |
| Independent Dir/Board Member | 22/06/2021 | - | |
| AMBRX INC | Director of Finance/CFO | 01/06/2021 | - |
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Director of Finance/CFO | 30/06/2021 | - |
| Chief Operating Officer | - | 28/04/2023 | |
| Corporate Secretary | 28/04/2023 | 05/06/2023 |
Historial de carrera de Sonja Nelson
Antiguos cargos conocidos de Sonja Nelson.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Inex Bio, Inc.
 Inex Bio, Inc. Financial ConglomeratesFinance Part of ImmunityBio, Inc., Inex Bio, Inc. is a South Korean company that provides investment services. The private company is located in South Korea. Inex Bio was acquired by NantKwest, Inc. from Inexbio Holdings LLC on March 30, 2015 for $37.85 million. | Director/Board Member | 01/10/2017 | 01/06/2021 |
| IMMUNITYBIO, INC. | Corporate Officer/Principal | 01/03/2021 | 01/06/2021 |
| IMMUNITYBIO, INC. | Comptroller/Controller/Auditor | 01/11/2015 | 11/06/2018 |
| Director of Finance/CFO | 11/06/2018 | 09/03/2021 | |
| ALTHEADX INC | Comptroller/Controller/Auditor | 01/07/2014 | 01/10/2015 |
| CADENCE PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/05/2012 | 01/06/2014 |
| Director/Board Member | 01/05/2012 | 01/06/2014 | |
Cricket Communications, Inc.
 Cricket Communications, Inc. Wireless TelecommunicationsCommunications Cricket Communications, Inc. provided mobile wireless services. It use to offer popular games, ring tones, wallpapers and international long distance and roaming services. The company was founded in 1999 and was headquartered in San Diego, CA. | Comptroller/Controller/Auditor | 01/09/2008 | 01/05/2012 |
| ░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
Formación de Sonja Nelson.
| Agnes Scott College | Undergraduate Degree |
| University of Pforzheim | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 10 |
| Alemania | 2 |
| Corea del Sur | 2 |
Operativa
| Comptroller/Controller/Auditor | 4 |
| Director of Finance/CFO | 4 |
| Director/Board Member | 3 |
Sectorial
| Health Technology | 8 |
| Consumer Services | 3 |
| Communications | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| MOTUS GI HOLDINGS, INC. | Health Technology |
| IMMUNITYBIO, INC. | Health Technology |
| Empresas privadas | 8 |
|---|---|
Cricket Communications, Inc.
Cricket Communications, Inc. Wireless TelecommunicationsCommunications Cricket Communications, Inc. provided mobile wireless services. It use to offer popular games, ring tones, wallpapers and international long distance and roaming services. The company was founded in 1999 and was headquartered in San Diego, CA. | Communications |
NantKwest, Inc.
 NantKwest, Inc. BiotechnologyHealth Technology NantKwest, Inc. engages in the research and development of immunotherapies. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The company was founded by Gary N. Keller and Hans Georg Klingemannon October 7, 2002 and is headquartered in San Diego, CA. | Health Technology |
AltheaDx, Inc.
 AltheaDx, Inc. Pharmaceuticals: MajorHealth Technology AltheaDx, Inc. operates as a commercial stage molecular diagnostics company which specializes in pharmacogenetics. It focuses in depression and anxiety, clinical publications, and IDgenetix testing process. The company was founded by Francois Ferre and Magda Marquet and is headquartered in San Diego, CA. | Health Technology |
Ambrx, Inc.
 Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Mallinckrodt Hospital Products, Inc. operates as a biopharmaceutical company, which develops and commercializes proprietary product candidates used in the hospital setting. The firm offers OFIRMEV (acetaminophen injection), a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The company was founded by Theodore R. Schroeder, David A. Socks, and Cam L. Garner on May 26, 2004 and is headquartered in Hazelwood, MO. | Health Technology |
NEON Enterprise Software LLC
 NEON Enterprise Software LLC Information Technology ServicesTechnology Services NEON Enterprise Software, Inc. develops software and data management solutions for compliance, data retention, IMS and DB2 tools. It offers Eclipse iRepair tool for viewing, analyzing and repairing IMS database data sets. The company was founded by John J. Moores in 1995 and is headquartered in Sugar Land, TX. | Technology Services |
Inex Bio, Inc.
Inex Bio, Inc. Financial ConglomeratesFinance Part of ImmunityBio, Inc., Inex Bio, Inc. is a South Korean company that provides investment services. The private company is located in South Korea. Inex Bio was acquired by NantKwest, Inc. from Inexbio Holdings LLC on March 30, 2015 for $37.85 million. | Finance |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Sonja Nelson
- Experiencia
